Page last updated: 2024-08-17

dinitrofluorobenzene and Hypersensitivity, Type III

dinitrofluorobenzene has been researched along with Hypersensitivity, Type III in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dore-Duffy, P; Elgebaly, SA; Forouhar, F1

Other Studies

1 other study(ies) available for dinitrofluorobenzene and Hypersensitivity, Type III

ArticleYear
Thiabendazole-induced suppression of renal damage in a murine model of autoimmune disease.
    The American journal of pathology, 1984, Volume: 115, Issue:2

    Topics: Animals; Autoimmune Diseases; Dinitrofluorobenzene; Disease Models, Animal; Drug Therapy, Combination; Female; Glomerulonephritis; Immune Complex Diseases; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Levamisole; Mice; Mice, Inbred Strains; Thiabendazole

1984